Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024

Stock Information for Adamas Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Adamas Pharmaceuticals Inc.

Asensus Surgical Announces Closing of Acquisition by KARL STORZ
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024
Asensus Surgical 2024 Special Meeting of Stockholders Is Adjourned
Independent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockholders Vote "FOR" the Pending Merger with KARL STORZ
Glass Lewis Recommends Asensus Surgical Stockholders Vote "FOR" Proposals Relating to Proposed Merger with KARL STORZ
Asensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery Program
Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology
Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.